Журнал Сердечная Недостаточность 2014 год Станет ли пациент с сердечной недостаточностью «пациентом–экспертом»?


Для доступа к данному материалу пожалуйста авторизуйтесь или зарегистрируйтесь

Зарегистрируйтесь Авторизуйтесь
2014/№2

Станет ли пациент с сердечной недостаточностью «пациентом–экспертом»?

Беграмбекова Ю. Л., Мареев В. Ю.
ФГБОУ ВПО «МГУ им. М. В. Ломоносова», 119991, Москва, ГСП-1, Ленинские горы, д. 1

Ключевые слова: амбулаторные пациенты, обучение больных, ХСН

DOI: 10.18087/rhfj.2014.2.1927

В обзоре представлено современное состояние проблемы обучения и амбулаторного наблюдения больных ХСН. Рассмотрены характеристики больных ХСН, обусловливающие сложности в реализации обучающих программ.
  1. «Saving Lives: Our Healthier Nation» Presented to Parliament by the Secretary of State for Healthby Command of Her Majesty, July 1999. Available at: https://www.gov.uk / government / uploads / system / uploads / attachment_data / file / 265576 / 4386.pdf.
  2. Department of Health. The expert patient: a new approach to chro­nic disease management in the 21st century. London: Stationery Office, 2001.
  3. Association of the British Pharmaceutical Industry. The expert patient – survey, October 1999. London: ABPI, 1999.
  4. Market and Opinion Research International, for Developing Patient Partnerships, formerly the Doctor Patient Partnership, DPP.Medicines and the British. London: MORI, 2003.
  5. Jordan Rau. Medicare Revises Hospitals' Readmissions Penalties – Again, Kaiser Health News 2012
  6. Faxon DP, Schwamm LH, Pasternak RC et al. Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease Management. Circulation. 2004 Jun 1;109 (21):2651–4.
  7. Куцепалов А. В. Влияние информированности пациентов на деятельность врача-хирурга (Опыт социологического анализа) доступно на: http://www.dissercat.com / content / vliyanie-informirovannosti-patsientov-na-deyatelnost-vracha-khirurga-opyt-sotsiologicheskogo
  8. Heidenreich PA, Albert NM, Allen LA et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013 May;6 (3):606–19.
  9. Fonarow GC; ADHERE Scientific Advisory Committee. The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med. 2003;4 Suppl 7: S21–30.
  10. Braunschweig F, Cowie MR, Auricchio A. What are the costs of heart failure? Europace. 2011 May;13 Suppl 2: ii13–7.
  11. Liao L, Allen LA, Whellan DJ. Economic burden of heart failure in the elderly. Pharmacoeconomics. 2008;26 (6):447–462.
  12. National Clinical Guideline Centre (UK). Chronic Heart Failure: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care: Partial Update [Internet]. London: Royal College of Physicians (UK); 2010 Aug. National Institute for Health and Clinical Excellence: Guidance.
  13. Bridging the quality gap: Heart failure. Kim Sutherland, March 2010; Published by The Health Foundation / Available at: http://www.health.org.uk / public / cms / 75 / 76 / 313 / 583 / Bridging%20the%20quality%20gap%20Heart%20Failure.pdf?realName=cXqFcz.pdf
  14. Howlett JG1, Ezekowitz JA, Podder M et al. Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF). Circ Cardiovasc Qual Outcomes. 2013 Sep 1;6 (5):534–42.
  15. Мареев В. Ю., Выгодин В. А., Беленков Ю. Н. ДиУретическая терапия Эффективными дозами перораЛьных диуретиков торасемида (диувера) и фуросемида в лечении больных с обострением Хронической Сердечной Недостаточности (ДУЭЛЬ–ХСН). Журнал Сердечная Недостаточность. 2011;12 (3):3–10.
  16. Беленков Ю. Н., Мареев В. Ю., Агеев Ф. Т., Даниелян М. О. Первые результаты национального эпидемиологического исследования – эпидемиологическое обследование больных ХСН в реальной практике (по обращаемости) – ЭПОХА–О–ХСН // Журнал СН. – 2003. – Т.4, № 3. – С.116–120.
  17. Агеев Ф. Т., Даниелян М. О., Мареев В. Ю., Беленков Ю. Н. Больные с хронической сердечной недостаточностью в российской амбулаторной практике: особенности контингента, диагностики и лечения (по материалам исследования ЭПОХА–О–ХСН). Журнал Сердечная Недостаточность. 2004;5 (1):4–7.
  18. Вишневский А. Г. Население России 2006: Четырнадцатый ежегодный демографический доклад. – Издательский дом ГУ-ВШЭ, 2008.
  19. Tsuyuki R, Yusuf S, Rouleau J et al. Combination neurohormonal blockade with ACE inhibitors angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study. Can J Cardiol. 1997;13 (12):1166–1174.
  20. Formiga F1, Chivite D, Manito N at al. Hospitalization due to acute heart failure. Role of the precipitating factors. Int J Cardiol. 2007 Aug 21;120 (2):237–41.
  21. Erk O. Precipitating factors for systolic and diastolic heart failure: a four-year follow-up of 192 patients. Hong Kong Med J. 2004 Apr;10 (2):97–101.
  22. Fonarow GC1, Abraham WT, Albert NM et al. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med. 2008 Apr 28;168 (8):847–54.
  23. Diaz A, Ciocchini C, Esperatti M at al. Precipitating factors leading to decompensation of chronic heart failure in the elderly patient in South-American community hospital. J Geriatr Cardiol. 2011 Mar;8 (1):12–4.
  24. Evangelista LS, Dracup K, Doering LV. Treatment-seeking delays in heart failure patients. J Heart Lung Transplant. 2000 Oct;19 (10):932–8.
  25. Wolfel EE. Can we predict and prevent the onset of acute decompensated heart failure? Circulation. 2007 Oct 2;116 (14):1526–9.
  26. Blackledge HM1, Tomlinson J, Squire IB. Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993–2001. Heart. 2003 Jun;89 (6):615–20.
  27. Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2007 Aug;154 (2):260–6.
  28. Tsuyuki RT1, McKelvie RS, Arnold JM et al. Acute precipitants of congestive heart failure exacerbations. Arch Intern Med. 2001 Oct 22;161 (19):2337–42.
  29. ESC Committee for Practice Guidelines (CPG), Dickstein K, Cohen-Solal A, Filippatos G et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008;10 (10):933–989.
  30. Мареев В. Ю., Агеев Ф. Т., Арутюнов Г. П. и др. Национальные рекомендации по диагностике и лечению Хронической Сердечной Недостаточности. Журнал Сердечная недостаточность. 2013;12 (7):379–472.
  31. Savard LA1, Thompson DR, Clark AM. A meta-review of evidence on heart failure disease management programs: the challenges of describing and synthesizing evidence on complex interventions. Trials. 2011 Aug 16;12:194.
  32. Clark AM, Thompson DR. What heart failure programme works best? Wrong question, wrong assumptions. Eur J Heart Fail. 2010 Dec;12 (12):1271–3.
  33. Clark AM1, Savard LA, Thompson DR. What is the strength of evidence for heart failure disease management programs? J Am Coll Cardiol. 2009 Jul 28;54 (5):397–401.
  34. Clark AM, Thompson DR. The future of management programmes for heart failure. Lancet. 2008;372 (9641):784–786.
  35. Glasziou P1, Meats E, Heneghan C, Shepperd S. What is missing from descriptions of treatment in trials and reviews? BMJ. 2008 Jun 28;336 (7659):1472–4.
  36. Jaarsma T, van der Wal MH, Lesman-Leegte I et al; Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH) Investigators. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med. 2008;168 (3):316–324.
  37. Jaarsma T, van Veldhuisen DJ. When, how and where should we «coach» patients with heart failure: the COACH results in perspective. Eur J Heart Fail. 2008 Apr;10 (4):331–3.
  38. McCall N, Cromwell J, Urato C,Rabiner D Evaluation ofphase 1 of the Medicare Health Support Pilot Program under traditional fee-for-service Medicare: 18‑month interim analysis.. Report to Congress. Baltimore Centers for Medicare and Medicaid Services; 2008 Oct. Available at: http://www.cms.gov / Research-Statistics-Data-and-Systems / Statistics-Trends-and-Reports / Reports / downloads / MHS_Second_Report_to_Congress_October_2008.pdf
  39. Krumholz HM1, Currie PM, Riegel B et al. A taxonomy for di­sease management: a scientific statement from the American Heart Association Disease Management Taxonomy Writing Group. Circulation. 2006 Sep 26;114 (13):1432–45.
  40. Boutron I1, Moher D, Altman DG et al. Methods and processes of the CONSORT Group: example of an extension for trials asses­sing nonpharmacologic treatments. Ann Intern Med. 2008 Feb 19;148 (4):W60–6.
  41. Агеев Ф. Т., Мареев В. Ю., Середенина Е. М., Беленков Ю. Н. Перспективы внедрения специализированных форм активного амбулаторного ведения больных с сердечной недостаточностью: структура, методика и предварительные результаты Российской программы «ШАНС». Журнал сердечная недостаточность. 2004;5 (6):268–271.
  42. Bruggink-André de la Porte PW, Lok DJ, van Wijngaarden J et al. Heart failure programmes in countries with a primary care-based health care system. Are additional trials necessary? Design of the DEAL-HF study. Eur J Heart Fail. 2005 Aug;7 (5):910–20.
  43. de la Porte PW1, Lok DJ, van Veldhuisen DJ et al. Added value of a physician-and nurse directed heart failure clinic: results from the Deventer-Alkmaar failure study. Heart. 2007 Jul;93 (7):819–25.
  44. Boyd C, Leff B, Weiss C et al. Multimorbidity Pattern Analyses and Clinical Opportunities: Congestive Heart Failure. December 2010 / Available at: http://www.chcs.org / usr_doc / CHF_final.pdf
  45. Braunstein JB1, Anderson GF, Gerstenblith G et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003 Oct 1;42 (7):1226–33.
  46. Moser DK, Watkins JF. Conceptualizing self-care in heart failure: a life course model of patient characteristics. J Cardiovasc Nurs. 2008 May-Jun;23 (3):205–18.
  47. Stoller EP, Forster LE, Pollow R, Tisdale WA. Lay evaluation of symptoms by older people: an assessment of potential risk. Health Educ Q. 1993 Winter;20 (4):505–22.
  48. van der Wal MH1, Jaarsma T, van Veldhuisen DJ. Non-compliance in patients with heart failure; how can we manage it? Eur J Heart Fail. 2005 Jan;7 (1):5–17.
  49. Ko DT1, Tu JV, Masoudi FA et al. Quality of care and outcomes of older patients with heart failure hospitalized in the United States and Canada. Arch Intern Med. 2005 Nov 28;165 (21):2486–92.
Беграмбекова Ю. Л., Мареев В. Ю. Станет ли пациент с сердечной недостаточностью «пациентом–экспертом»? Журнал Сердечная Недостаточность. 2014;83 (2):110–120

Для доступа к данному материалу пожалуйста авторизуйтесь или зарегистрируйтесь

Зарегистрируйтесь Авторизуйтесь
Ru En